AI Generated
Oct 31, 2026, 11:04
Abhivandan Nagia: The Expanding Clinical Pipeline in Hemophilia A
Abhivandan Nagia, Director at ABNewswire, shared a post on LinkedIn:
“Hemophilia A Clinical Trial Pipeline Gains Momentum: 40 plus Companies Lead the Charge in Pioneering New Treatments | DelveInsight:
The Hemophilia A clinical trial analysis report delivers important insights into ongoing research on 40 plus pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
(Albany, US) On October 29, 2026- DelveInsight’s ‘Hemophilia A Pipeline Insights 2026‘ report provides comprehensive insights… ”
Stay updated with Hemostasis Today.
-
Oct 31, 2026, 10:54Bartosz Puła: New Advances in Hematology Featured in Acta Haematologica Polonica
-
Oct 31, 2026, 10:47Abhishek Kumar: Amplifying Patient Voices to Transform Haemophilia Care in Bihar
-
Oct 31, 2026, 10:42Josa Hanzlik: The Impact of Double Red Cell Donation
-
Oct 31, 2026, 09:10Alberto F. Chambi: Stroke and Cerebral Venous Thrombosis at High Altitude
-
Oct 31, 2026, 08:52Julianna Argueta: ATHN Data Summit – Advancing Collaboration in Blood Disorders
-
Oct 31, 2026, 08:11Paul Kariuki: Expanding Access to Plasma-Derived Medicines Across Africa
-
Oct 31, 2026, 07:09Akshay Sharma: Gene therapy for sickle cell disease
-
Oct 31, 2026, 07:00Owen McCarty: The Hidden Immune Mechanism Behind Chemotherapy-Associated Platelet Loss
-
Oct 31, 2026, 06:51Thijn Brummelkamp: SMIM1 Reveals a Novel Pathway for Cellular Iron Uptake Through Haemoglobin